Keywords: encouraging, ph, data, avalon, avn944, usa, pharmaceuticals

Encouraging Ph I data for Avalon's AVN944

Article | 22 December 2006

Print This

The USA's Avalon Pharmaceuticals says that Phase I study data on AVN944, its lead product candidate, for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in